Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA grants Breakthrough Therapy designation to Novartis CTL019 for DLBCL

pharmaceutical-technologyApril 20, 2017

Tag: FDA , drug

PharmaSources Customer Service